Literature DB >> 16600071

Review of successful treatment for Helicobacter species in laboratory mice.

Angela Kerton1, Paul Warden.   

Abstract

Three variations of the amoxycillin-based triple therapy (amoxycillin, metronidazole and bismuth) were administered in the diet, by oral gavage or in the diet in conjunction with cross-fostering on to Helicobacter-free foster mothers to mice naturally infected with H. hepaticus and/or H. bilis. The presence of Helicobacter species was determined by polymerase chain reaction (PCR) analysis of faecal pellets. Helicobacter infection was eliminated in 50% of strains of mice treated by oral gavage; 57% of strains of mice treated by medicated diet alone and 100% of strains of mice treated with the medicated diet in conjunction with cross-fostering on to Helicobacter-free foster mothers. Eight strains of mice were successfully treated for Helicobacter infection over a two-year period. The mouse colony has been maintained Helicobacter free, as determined by PCR analysis and has remained off treatment from December 2002 to March 2005.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16600071     DOI: 10.1258/002367706776319033

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  11 in total

1.  Eradication of Helicobacter spp. by using medicated diet in mice deficient in functional natural killer cells and complement factor D.

Authors:  Maria Del Carmen Martino-Cardona; Sarah E Beck; Cory Brayton; Julie Watson
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-05       Impact factor: 1.232

2.  Antibiotic administration alters the community structure of the gastrointestinal micobiota.

Authors:  Courtney J Robinson; Vincent B Young
Journal:  Gut Microbes       Date:  2010-05-24

3.  Prevention of murine norovirus infection in neonatal mice by fostering.

Authors:  Susan R Compton
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-05       Impact factor: 1.232

4.  Results of Survey Regarding Prevalence of Adventitial Infections in Mice and Rats at Biomedical Research Facilities.

Authors:  James O Marx; Diane J Gaertner; Abigail L Smith
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-09-01       Impact factor: 1.232

5.  Helicobacter bilis-Associated Suppurative Cholangitis in a Patient with X-Linked Agammaglobulinemia.

Authors:  Nicolas Degand; Justine Dautremer; Benoît Pilmis; Agnès Ferroni; Fanny Lanternier; Julie Bruneau; Olivier Hermine; Stéphane Blanche; Xavier Nassif; Olivier Lortholary; Marc Lecuit
Journal:  J Clin Immunol       Date:  2017-08-31       Impact factor: 8.317

6.  The use of cross-foster rederivation to eliminate murine norovirus, Helicobacter spp., and murine hepatitis virus from a mouse colony.

Authors:  James E Artwohl; Jeanette E Purcell; Jeffrey D Fortman
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-11       Impact factor: 1.232

7.  Prevalence of murine Helicobacter spp. Infection is reduced by restocking research colonies with Helicobacter-free mice.

Authors:  Jennifer Ls Lofgren; Michael Esmail; Melissa Mobley; Amanda McCabe; Nancy S Taylor; Zeli Shen; Susan Erdman; Christine Hewes; Mark T Whary; James G Fox
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-07       Impact factor: 1.232

8.  Use of Neonatal Fostering To Remove Helicobacter spp. from Deer Mice (Peromyscus maniculatus).

Authors:  Kathleen R Pritchett-Corning; Harry E Peery; Janet P Crossland; Heather M Wyatt; Marilyne Stuart; Carmel E Mothersill
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-07       Impact factor: 1.232

Review 9.  Helicobacter hepaticus, a new pathogenic species of the Helicobacter genus: Similarities and differences with H. pylori.

Authors:  Tahereh Falsafi; Mohaddese Mahboubi
Journal:  Iran J Microbiol       Date:  2013-09

10.  The effect of Helicobacter pylori eradication on liver enzymes in patients referring with unexplained hypertransaminasemia.

Authors:  Hassan Salehi; Mohammad Minakari; Arezoo Yaghoutkar; Elham Tabesh; Marziyeh Salehi; Leila Mirbagher
Journal:  Adv Biomed Res       Date:  2014-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.